Like every other cell in the human body, cancer cells also produce their own share of proteins for survival. During this production process, cells often encounter a glitch called ribosomal frameshifting. This exceptionally rare event occurs roughly once in every 100,000 translation events, when the ribosome, while reading genetic instructions to make a protein, shifts its reading position. A recent Nature study investigated whether this protein-building glitch in cancer cells can be turned into a targeted cancer therapy.